Financial Toxicity Monitoring in a Randomized Controlled Trial of Patient-Reported Outcomes During Cancer Treatment (Alliance AFT-39)
      QxMD      Google Scholar   
Citation:
J Clin Oncol vol 41 (29) 4652-63
Year:
2023
Type:
Manuscript
Funding:
PCORI
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
13
Parents:
None
Children:
None
Program:
CCP
Primary Committee:
CCDR
Sec. Committees:
   
Pharmas:
 
Grants:
IHS-1511-33392, P30-CA016086  
Corr. Author:
 
Authors:
                                   
Networks:
LAPS-IL036, LAPS-MN026, LAPS-NC007, LAPS-NY016, NY167   
Study
AFT-39
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: